Showing 2,581 - 2,600 results of 3,564 for search '"Non cancerous"', query time: 0.61s Refine Results
  1. 2581

    The future of Funds for Innovative Medicines: results from a Delphi Study by Claudio Jommi, Patrizio Armeni, Arianna Bertolani, Francesco Costa, Monica Otto

    Published 2021-03-01
    “…Introduction: Dedicated Funds for Innovative Medicines were introduced in 2017 for cancer and non-cancer drugs in Italy. After three years, their impact on patient access to the relevant treatments and critical issues about their management has been poorly investigated. …”
    Get full text
    Article
  2. 2582

    Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer by Chong Chen, Fengshuo Xu, Shiqi Yuan, Xuenuo Zhao, Mengmeng Qiao, Didi Han, Jun Lyu

    Published 2023-02-01
    “…Abstract Background Developments in medical technology are resulting in continuous decreases in the cancer mortality rate of patients with gallbladder cancer, while non‐cancer deaths in cancer patients are becoming more common. …”
    Get full text
    Article
  3. 2583

    Evaluation of Carcinogenic and Non-Carcinogenic Risk of Heavy Metals Due to the Consumption of Vegetables Produced in the Greenhouse of Markazi Province by Kourosh Mokhtari, Hossein Mazaheri, Amir Hossein Baghaie, Ali Hassani Joshaghani

    Published 2019-01-01
    “…Methods: In this descriptive study, sampling of cucumber, tomato, and bell pepper produced in the greenhouses of Markazi province was done randomly and the concentration of Pb, Cd, Cu, Ni and NO 3 of them were determined. Non-cancer risk related to heavy metals and NO 3 sorption from vegetables was evaluated using the EPA method for men and women. …”
    Get full text
    Article
  4. 2584

    LncRNA PLAC 2 downregulated miR-21 in non-small cell lung cancer and predicted survival by Huan Xia, Ming Xiu, Jinying Gao, Hongyu Jing

    Published 2019-09-01
    “…Results PLAC2 was down-regulated, while miR-21 was up-regulated in NSCLC tissues compared to non-cancer tissues. Low PLAC2 levels in NSCLC tissues were associated with poor survival of NSCLC patients. …”
    Get full text
    Article
  5. 2585

    Biological Monitoring of Glyphosate Exposure among Knapsack Sprayers in Khon Kaen, Thailand by Sunisa Chaiklieng, Kodchakorn Uengchuen, Netsirin Gissawong, Supalax Srijaranai, Herman Autrup

    Published 2024-05-01
    “…The internal dose ranged from 0.0001 to 0.0021 mg/kg b.w./day. The non-cancer HQ showed no potential health risk concerns (HQ < 1). …”
    Get full text
    Article
  6. 2586

    Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population by Jason E. Miller, Raghu P. Metpally, Thomas N. Person, Sarathbabu Krishnamurthy, Venkata Ramesh Dasari, Manu Shivakumar, Daniel R. Lavage, Adam M. Cook, David J. Carey, Marylyn D. Ritchie, Dokyoon Kim, Radhika Gogoi, on behalf of the DiscovEHR collaboration

    Published 2019-05-01
    “…Results Eight genes were identified as having increased burden in the EMCA cohort relative to the non-cancer control cohort. None of the eight genes had an increased burden in the other hormone related cancer cohort from GHS, suggesting they can help characterize the underlying genetic variation that gives rise to EMCA. …”
    Get full text
    Article
  7. 2587

    Meeting Physician Compliance Recommendations in the Management of Opioids in Chronic Pain: The Chronic Pain Management Registry (CPMR) by Paul Langley

    Published 2019-02-01
    “…The purpose of the present commentary is to expand upon the role of the CPMR in the management of opioids in detailing the concordance of the CPMR data collection requirements with the latest recommendations of the American Society of Interventional Pain Physicians (ASIPP) for responsible, safe and effective opioid prescribing in chronic non-cancer pain. Given ongoing concerns with opioid misuse and abuse, the opioid epidemic, physician practices are at risk for what may be judged as poor therapy decisions in evaluating medical necessity and a failure to monitor effectively response to therapy. …”
    Get full text
    Article
  8. 2588

    Establishing Credibility for Medical Marijuana: The Proposed Prometheus Dispensary Registry for Botanical Cannabis by Paul Langley

    Published 2019-01-01
    “…The registry tracks and reports on patients over the course of treatment with botanical cannabis with the focus on severe or chronic non-cancer pain, severe nausea, persistent muscle spasms and seizures, together with prevalent comorbidities – fatigue, anxiety, depression and sleep. …”
    Get full text
    Article
  9. 2589

    Sacrococcygeal teratoma: evaluation of its approach, treatment and follow-up in two reference children cancer centers in Brazil / Rio de Janeiro by VANESSA DO NASCIMENTO SANTOS, SIMONE DE OLIVEIRA COELHO, ALAN ARAUJO VIEIRA

    Published 2022-09-01
    “…Conclusion: the characteristic of being a non-cancer center can interfere with the full application of the current protocol for the treatment of sacrococcygeal teratoma. …”
    Get full text
    Article
  10. 2590

    Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies by Brian A. Baldo

    Published 2022-02-01
    “…Of the 110 mAbs preparations currently approved by the FDA and/or EMA, 46 (including 13 antibody–drug conjugates) recognizing 29 different targets are indicated for the treatment of cancers, and 66, recognizing 48 different targets, are indicated for non-cancer disorders. Despite their specific targeting with the expected accompanying reduced collateral damage for normal healthy non-involved cells, mAbs, may cause types I (anaphylaxis, urticaria), II (e.g., hemolytic anemia, possibly early-onset neutropenia), III (serum sickness, pneumonitis), and IV (Stevens–Johnson syndrome, toxic epidermal necrolysis) hypersensitivities as well as other cutaneous, pulmonary, cardiac, and liver adverse events. …”
    Get full text
    Article
  11. 2591

    An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours by Joseph Robinson, Katharine Whitworth, Elizabeth Jinks, Zsuzsanna Nagy, Roy Bicknell, Steven P Lee

    Published 2020-10-01
    “…Elevated levels of CLEC14A transcripts were identified in some non‐cancer pathologies; such comorbidities may need to be excluded from trials of therapies targeting this marker. …”
    Get full text
    Article
  12. 2592

    Evaluation of N-NOSE as a surveillance tool for recurrence in gastric and esophageal cancers: a prospective cohort study by Sayuri Iitaka, Akihiro Kuroda, Tomonori Narita, Hideyuki Hatakeyama, Masayo Morishita, Umbhorn Ungkulpasvich, Takaaki Hirotsu, Eric di Luccio, Koichi Yagi, Yasuyuki Seto

    Published 2024-12-01
    “…While N-NOSE has been validated to distinguish between cancer and non-cancer, and its performance compared to traditional markers has been proven, it has not been studied for recurrence. …”
    Get full text
    Article
  13. 2593

    Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma by Guohong Liu, Chunjue Yuan, Jiaojiao Ma, Yunbao Pan, Yunbao Pan, Haibo Xu

    Published 2021-03-01
    “…We assessed the relative proportion of 22 Infiltrating immune cell types in both HNSCC and adjacent non-cancer tissues using Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts (CIBERSORT) method, identifying the influence of the immune cells content in tumor staging and survival prediction. …”
    Get full text
    Article
  14. 2594
  15. 2595

    Opioid-induced respiratory depression and risk factors in a tertiary hospital: A retrospective study by Nabil A. Almouaalamy, Majed Alshamrani, Waleed K. Alnejadi, Ziyad M. Alharbi, Faisal M. Aldosari, Enad F. Alsulimani, Saif A. Saif, Mohammed K. Aldawsari

    Published 2022-08-01
    “…Background: Opioids are potent analgesics used for the treatment of moderate to severe acute and chronic cancer and non-cancer pain. However, opioid usage may be limited by negative side effects, such as potentially life-threatening respiratory depression. …”
    Get full text
    Article
  16. 2596

    Cognitive effects of low dose of ionizing radiation – Lessons learned and research gaps from epidemiological and biological studies by Elisa Pasqual, François Boussin, Dimitry Bazyka, Arvid Nordenskjold, Michiko Yamada, Kotaro Ozasa, Simonetta Pazzaglia, Laurence Roy, Isabelle Thierry-Chef, Florent de Vathaire, Mohammed Abderrafi Benotmane, Elisabeth Cardis

    Published 2021-02-01
    “…The last decades have seen increased concern about the possible effects of low to moderate doses of ionizing radiation (IR) exposure on cognitive function.An interdisciplinary group of experts (biologists, epidemiologists, dosimetrists and clinicians) in this field gathered together in the framework of the European MELODI workshop on non-cancer effects of IR to summarise the state of knowledge on the topic and elaborate research recommendations for future studies in this area.Overall, there is evidence of cognitive effects from low IR doses both from biology and epidemiology, though a better characterization of effects and understanding of mechanisms is needed.There is a need to better describe the specific cognitive function or diseases that may be affected by radiation exposure. …”
    Get full text
    Article
  17. 2597

    Resentful, Resigned and Respectful: Opioid Analgesics, Pain and Control, a Qualitative Study by Richard Cooper, Catriona Matheson, Emily Pagan, Helen Radford

    Published 2025-02-01
    “…This study aimed to explore non-cancer patients’ experiences and views of taking opioid analgesics to manage their pain. …”
    Get full text
    Article
  18. 2598
  19. 2599

    Understanding the Attitudes and Beliefs of Oncologists Regarding the Transitioning and Sharing of Survivorship Care by Courtney H. Coschi, Daryl Bainbridge, Jonathan Sussman

    Published 2021-12-01
    “…Understanding these issues is critical to developing policies supporting comprehensive survivorship care models that address both cancer and non-cancer health needs. The demonstrated feasibility of this project warrants a larger-scale survey of oncologists with respect to the transition of survivorship care to PCPs, to further inform effective interventions to support high-quality survivorship care.…”
    Get full text
    Article
  20. 2600

    Advances in Brain Tumor Surgery for Glioblastoma in Adults by Montserrat Lara-Velazquez, Rawan Al-Kharboosh, Stephanie Jeanneret, Carla Vazquez-Ramos, Deependra Mahato, Daryoush Tavanaiepour, Gazanfar Rahmathulla, Alfredo Quinones-Hinojosa

    Published 2017-12-01
    “…In an attempt to achieve optimal safe resection, advances in approaches allowing intraoperative analysis of cancer and non-cancer tissue have been developed and applied in humans resulting in improved outcomes. …”
    Get full text
    Article